August 29, 2024Open Access

Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes

Key Points

Key points are not available for this paper at this time.

Abstract

Evidence for the effect of favipiravir treatment of acute COVID-19 on recovery, hospital admissions and longer-term outcomes in community settings is limited.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Richard Hobbs

Oghenekome A. Gbinigie-Thompson

Milensu Shanyinde

Journals

Journal of Infection

Actions

Institutions

University of Oxford

Vanderbilt University

University of Southampton

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study